Abstract

The object of the present invention is the design, synthesis, and pharmacological evaluation of novel diphenylmethane core molecules, capable of simultaneously promoting activation of the autophagy process and lipid catabolism, both in vitro and in vivo. Their dual activity may represent a novel approach for the treatment of neurodegenerative diseases, such as Alzheimer.

Research Institution

Università di Pisa

Numero di pubblicazione

IT201900018893A1

TRL

N.A.

Technologies, Systems, Applications

Biomedical, New drugs development